Inventor

SCOLA PAUL MICHAEL

US83 patents

⚠️ This page may combine multiple inventors who share the name “SCOLA PAUL MICHAEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BRISTOL MYERS SQUIBB CO

42 patents

US7449479B2Nov 11, 2008

Hepatitis C virus inhibitors

BRISTOL MYERS SQUIBB CO67 citations99

US6995174B2Feb 7, 2006

Hepatitis C virus inhibitors

BRISTOL MYERS SQUIBB CO194 citations98

US7173004B2Feb 6, 2007

Macrocyclic isoquinoline peptide inhibitors of hepatitis C virus

BRISTOL MYERS SQUIBB CO90 citations97

US7135462B2Nov 14, 2006

Hepatitis C virus inhibitors

BRISTOL MYERS SQUIBB CO72 citations97

US7132504B2Nov 7, 2006

Hepatitis C virus inhibitors

BRISTOL MYERS SQUIBB CO95 citations97

US7041698B2May 9, 2006

Hepatitis C virus inhibitors

BRISTOL MYERS SQUIBB CO135 citations97

US6878722B2Apr 12, 2005

Substituted cycloalkyl P1′ hepatitis C virus inhibitors

BRISTOL MYERS SQUIBB CO134 citations97

US9308236B2Apr 12, 2016

Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions

BRISTOL MYERS SQUIBB CO51 citations96

US7915291B2Mar 29, 2011

Hepatitis C virus inhibitors

BRISTOL MYERS SQUIBB CO40 citations96

US9879046B2Jan 30, 2018

Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions

BRISTOL MYERS SQUIBB CO17 citations93

US8710229B2Apr 29, 2014

Hepatitis C virus inhibitors

BRISTOL MYERS SQUIBB CO10 citations92

US7741281B2Jun 22, 2010

Hepatitis C virus inhibitors

BRISTOL MYERS SQUIBB CO20 citations92

US7323447B2Jan 29, 2008

Hepatitis C virus inhibitors

BRISTOL MYERS SQUIBB CO50 citations92

US7309708B2Dec 18, 2007

Hepatitis C virus inhibitors

BRISTOL MYERS SQUIBB CO39 citations92

US10633419B2Apr 28, 2020

Immunomodulators

BRISTOL MYERS SQUIBB CO7 citations84

US10143746B2Dec 4, 2018

Immunomodulators

BRISTOL MYERS SQUIBB CO9 citations84

US9944678B2Apr 17, 2018

Immunomodulators

BRISTOL MYERS SQUIBB CO8 citations84

US9861680B2Jan 9, 2018

Immunomodulators

BRISTOL MYERS SQUIBB CO10 citations84

US9856292B2Jan 2, 2018

Immunomodulators

BRISTOL MYERS SQUIBB CO12 citations84

US9850225B2Dec 26, 2017

Compounds useful as immunomodulators

BRISTOL MYERS SQUIBB CO13 citations84

US9809625B2Nov 7, 2017

Immunomodulators

BRISTOL MYERS SQUIBB CO8 citations84

US9732119B2Aug 15, 2017

Immunomodulators

BRISTOL MYERS SQUIBB CO14 citations84

US9227940B2Jan 5, 2016

Hepatitis C virus inhibitors

BRISTOL MYERS SQUIBB CO3 citations84

US7964560B2Jun 21, 2011

Hepatitis C virus inhibitors

BRISTOL MYERS SQUIBB CO10 citations84

US7772180B2Aug 10, 2010

Hepatitis C virus inhibitors

BRISTOL MYERS SQUIBB CO17 citations84

US10538555B2Jan 21, 2020

Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions

BRISTOL MYERS SQUIBB CO8 citations83

US7772183B2Aug 10, 2010

Hepatitis C virus inhibitors

BRISTOL MYERS SQUIBB CO15 citations83

US9850283B2Dec 26, 2017

Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions

BRISTOL MYERS SQUIBB CO12 citations82

US7763584B2Jul 27, 2010

Hepatitis C virus inhibitors

BRISTOL MYERS SQUIBB CO18 citations82

US8889871B2Nov 18, 2014

Hepatitis C virus inhibitors

BRISTOL MYERS SQUIBB CO3 citations74

US11578054B2Feb 14, 2023

Compounds useful as immunomodulators

BRISTOL MYERS SQUIBB CO2 citations73

US11358988B2Jun 14, 2022

Immunomodulators

BRISTOL MYERS SQUIBB CO2 citations73

US11046675B2Jun 29, 2021

Substituted isoquionline derivatives as immunomudulators

BRISTOL MYERS SQUIBB CO4 citations73

US10358463B2Jul 23, 2019

Immunomodulators

BRISTOL MYERS SQUIBB CO7 citations73

US10144706B2Dec 4, 2018

Compounds useful as immunomodulators

BRISTOL MYERS SQUIBB CO7 citations73

US8916702B2Dec 23, 2014

Compounds for the treatment of hepatitis C

BRISTOL MYERS SQUIBB CO4 citations73

US8697706B2Apr 15, 2014

Compounds for the treatment of hepatitis C

BRISTOL MYERS SQUIBB CO4 citations73

US8629150B2Jan 14, 2014

Compounds for the treatment of hepatitis C

BRISTOL MYERS SQUIBB CO4 citations73

US10450347B2Oct 22, 2019

Immunomodulators

BRISTOL MYERS SQUIBB CO6 citations72

US12403174B2Sep 2, 2025

Immunomodulators

BRISTOL MYERS SQUIBB CO0 citations63

US9636375B2May 2, 2017

Hepatitis C virus inhibitors

BRISTOL MYERS SQUIBB CO1 citations63

US8987264B2Mar 24, 2015

1,3,5-triazine derivatives of spiro bicyclic oxalamide-compounds for treatment of hepatitis C

BRISTOL MYERS SQUIBB CO2 citations63

WANG TAO

4 patents

US8586584B2Nov 19, 2013

Compounds for the treatment of hepatitis C

WANG TAO7 citations84

US8445490B2May 21, 2013

Compounds for the treatment of hepatitis C

WANG TAO11 citations84

US8933066B2Jan 13, 2015

Compounds for the treatment of hepatitis C

WANG TAO4 citations73

US8741884B2Jun 3, 2014

Compounds for the treatment of hepatitis C

WANG TAO4 citations73

WANG ALAN XIANGDONG

1 patent

US8299094B2Oct 30, 2012

Hepatitis C virus inhibitors

WANG ALAN XIANGDONG15 citations92

SIN NY

1 patent

US8163921B2Apr 24, 2012

Hepatitis C virus inhibitors

SIN NY9 citations79

HIEBERT SHELDON

1 patent

US8957203B2Feb 17, 2015

Hepatitis C virus inhibitors

HIEBERT SHELDON4 citations68

SUN LI-QIANG

1 patent

US8765944B2Jul 1, 2014

Compounds for the treatment of hepatitis C

SUN LI-QIANG7 citations68

Showing the top 50 of 83 patents by PatentIndex Score.